Vertical Human Immunodeficiency Virus Type 1 - HIV-1 -Transmission - A Review

Memorias do Instituto Oswaldo Cruz

Volumn 96, Issue 1, 2001, Pages 1-14

  Bongertz, Vera ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

HIV; Vertical HIV 1 transmission

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

DISEASE TRANSMISSION; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR; T LYMPHOCYTE; VIRUS LOAD;

AIDS VACCINES; ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; GENOTYPE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 0035230427     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762001000100001     Document Type: Review

References (158)

1. Aleixo LF, Goodenow MM, Sleasman JW 1997. Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus. J Pediatr 130: 906-914.
2. Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Burns D, Delapenha R, DeHovitz J, Cohen M, Meyer W, Bremer J, Kovacs A 1999. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. AIDS 13: 1717-1726.
3. Autran B, Hadida F, Haas G 1996. Evolution and plasticity of CTL responses against HIV. Curr Opin Immunol 8: 546-553.
4. Ayyavoo V, Ugen KE, Fernandes LS, Goedert JJ, Rubinstein A, Williams WV, Weiner DB 1996. Analysis of genetic heterogeneity, antigenicity, and biological characteristics of HIV-1 in a maternal transmitter and nontransmitter patient pair. DNA Cell Biol 15: 571-580.
5. Bagarazzi ML, Boyer JD, Javadn MH, Chattergoon MA, Shah AR, Cohen AD, Bennett MK, Ciccarelli RB, Ugen KE, Weiner DB 1999. Systemic and mucosal immunity elicited after both intramuscular and intravaginal delivery of HIV-1 DNA plasmid vaccines to pregnant chimpanzees. J Inject Dis 180: 1351-1355.
6. Bakshi SS, Tetali S, Abrams EJ, Paul MO, Pahwa SG 1995. Repeatedly positive human immunodeficiency virus type 1 DNA polymerase chain reaction in human immunodeficiency virus-exposed seroreverting infants. Pediatr Infect Dis J 14: 658-662.
7. Boletim Epidemiológico AIDS 1999. Ministério da Saúde, Secretaria de Politicas de Saúde, Coordenação Nacional de DST e Aids XII(3).
8. Bongertz V, Costa CI, Guimarães ML, Soares-da-Costa MFG, Grinsztejn B, The HEC/FIOCRUZ AIDS Clinical Research Group, Bastos FI, Pilotto JH, João Filho EC, Loureiro R, Chequer P, Telles PR, Galvão-Castro B, Morgado MG 1998. HIV specific humoral immune response in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 93: 391-398.
9. Bongertz V, Costa CI, Guimarães ML, Grinsztejn B, João Filho EC, Calvet G, Pilotto JH, Morgado MG and The HEC/FIOCRUZ AIDS Clinical Research Group 1999. Rev Inst Med Trop São Paulo 41: S-38.
10. Borkowsky W, Krasinski K, Cao Y, Ho D, Pollack H, Moore T, Chen SH, Allen M, Tao PT 1994. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J Pediatr 125: 345-351.
11. Bravo R, Gutiérrez M, Soriano V, Mellado MA, Perez-Labad ML, Mas A, Gonzalez-Lahoz J, Martin-Fontelas P 1996. Lack of evidence for viral clearance in children born to HIV-infected mothers. AIDS 10: 1744-1745.
12. Bratt G, Leandersson AC, Albert J, Sandstrom E, Wahren B 1998. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals. AIDS 12: 729-736.
13. Brossard Y, Aubin JT, Mandelbrot L, Bignozzi C, Brand D, Chaput A, Roume J, Mulliez N, Mallet F, Agut H 1995. Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction studs on 100 fetal thymuses. AIDS 9: 359-366.
14. Bulterys M, Landesman S, Burns D, Rubinstein A, Goedert JJ 1997. Sexual behaviour and injecting drug use during pregnancy and vertical transmission of HIV-1. AIDS 15: 76.
15. Burger H, Kovacs A, Weiser B, Grimson R, Nachman S, Tropper P, van Bennekum AM, Elie MC, Blaner WS 1997. Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States. J Aids Hum Retrovirol 14: 321-326.
16. Campodonico M, Fay F, Fay D, Hernandez EP, Taborda M 1998. Does a particular HIV-1 subtype strain favor vertical transmission? 12th World AIDS Conf, Geneva, Switzerland, Abstract 23302.
17. Cherry M 2000. Letter fuels South Africa's AIDS furore. Nature 404: 911.
18. Cheynier R, Langlade-Demoyen P, Marescot MR, Blanche S, Blondin G, Wain-Hobson S, Griscelli C, Vilmer E, Plata F 1992. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 22: 2211-2217.
19. Chouquet C, Burgard M, Richardson S, Rouzioux C, Costagliola D 1997. Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method. AIDS 11: 1183-1184.
20. Chu SY, Oxtoby MJ, Kilbourne BW 1991. The impact of the HIV epidemic on mortality in children, United States. Pediatrics 87: 806-810.
21. Colgrove RC, Pitt J, Chung PH, Welles SL, Japour AJ 1998. Selective vertical transmission of HIV-1 antiretroviral resistance mutations. AIDS 12: 2281-2288.
22. Colognesi C, Halapi E, Jansson M, Hodara V, Steuer G, Tresoldi E, Leitner T, Scarlatti G 1997. The role of virologie and immunologic factors in mother-to-child transmission of HIV-1. Am J Reprod Immunol 38: 197-200.
23. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy JF, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331: 1173-1180.
24. Contag CH, Ehrnst A, Duda J, Bohlin AB, Lindgren S, Learn GH, Mullins JI 1997. Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes. J Virol 71: 1292-1300.
25. Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM, Cunningham B, Oleske J 1999. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 281: 151-157.
26. David FJE, Autran B, Tran HC, Menu E, Raphael M, Debre P, Hsi BL, Wegman TG, Barré-Sinoussi F, Chaouat G 1992. Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1. Clin Exp Immunol 88: 10-16.
27. De Andreis C, Simoni G, Castagna C, Sacchi L, Sirchia SM, Garagiola I, Persico T, Serafini P, Pardi G, Semprini AE 1997. Absence of detectable maternal DNA and identification of proviral HIV in the cord blood of two infants who became HIV-infected. AIDS 11: 840-841.
28. De Rossi A, Ometto L, Masiero S, Zanchetta M, Chieco-Bianchi L 1997. Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection. Acta Paediatr Suppl. 421: 22-28.
29. Devash Y, Calvelli TA, Wood DG, Reagan KJ, Rubinstein A 1990. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci USA 87: 3445-3449. Published erratum appears in Proc Natl Acad Sci USA 88: 1084.
30. Duliege AM, Amos CI, Felton S, Biggar RJ, Goedert JJ 1995. The International Registry of HIV-exposed twins: birth order, delivery route, and concordance in the transmission of HIV-1 from mothers to twins. J Pediatr 126: 625-632.
31. Dunn DT, Brandt CD, Krivine A, Cassol SA, Roques P, Borkowsky W, De Rossi A, Denamur E, Ehrnst A, Loveday C 1995. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intrapartum transmission. AIDS 9: F7-11.
32. Dunn DT, Newell ML, Ades AE, Peckham CS 1992. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 340: 585-588.
33. Dunn DT, Tess BH, Rodrigues LC, Ades AE 1998. Mother-to-child transmission of HIV: implications of variation in maternal infectivity. AIDS 12: 2211-2216.
34. Eastman PS, Shapiro DE, Coombs RW, Frenkel LM, McSherry GD, Britto P, Herman SA, Sperling RS 1998. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. J Infect Dis 177: 557-564.
35. Edelstein RE, Arcuino LA, Hughes JP, Melvin AJ, Mohan KM, King PD, McLellan CL, Murante BL, Kassman BP, Frenkel LM 1997. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/ delta32ccr5 heterozygotes. J Aids Hum Retrovirol 16: 243-246.
36. Essajce S, Pollak H, Rochford G, Oeansky I, Krasinski K, Borkowsky W 1996. Characterization of the relationship between quasispecies repertoire in HIV-1 infected mothers and their infants using heteroduplex analysis. 36th ICAAC Conference, Abstract 1071.
37. European Collaborative Study 1999. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 13: 1377-1385.
38. Fang G, Burger H, Grimson R, Tropper P, Nachman S, Mayers D, Weislow O, Moore R, Reyelt C, Hutcheon N, Baker D, Weiser B 1995. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 92: 12100-12104.
39. Ffrench R, Maplestone MA, Goode M, Hughes C, Stewart GJ, Benson EM, Ziegler JB 1998. Strong cytotoxic T cell responses detected in the majority of uninfected infants born to HIV-positive mothers. 12th World AIDS Conf Geneva, Switzerland, Abstract 31157.
40. Frenkel LM, Mullins JI, Learn GH, Manns-Arcuino L, Herring BL, Kalish ML, Steketee RW, Thea DM, Nichols JE, Liu SL, Harmache A, He X, Muthui D, Madan A, Hood L, Haase AT, Zupancic M, Staskus K, Wolinsky S, Krogstad P, Zhao J, Chen I, Koup R, Ho D, Korber B, Apple R, Coombs RW, Pahwa S, Roberts Jr NJ 1998. Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science 280: 1073-1077.
41. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C, Lew JF 1999. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 341: 394-402.
42. Gibb D, Giacomelli A, Masters J, Spoulou V, Ruga E, Griffiths H, Kroll S, Giaquinto C, Goldblatt D 1996. Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J 15: 1097.
43. Gras G, Beyssen V, Tranchot-Diallo J, Parnet-Mathieu F, Lasfargues G, Courpotin C, Dormont D 1998. Neutralizing antibodies and complement-mediated, antibody-dependent enhancement (C'-ADE) of human immunodeficiency virus infection in its vertical transmission. Am J Reprod Immunol 39: 381-386.
44. Greco P, Vimercati A, Fiore JR, Kardashi A, Lotesoriere V, Loverro G, Milillo F, Selvaggi L 1998. Maternal viral and gestational risk factors in vertical transmission of HIV-1 infection. Minerva Ginecol 50: 449-454.
45. Greenberg BL, Semba RD, Vink PE, Farley JJ, Sivapalasingam M, Steketee RW, Thea DM, Schoenbaum EE 1997. Vitamin A deficiency and maternal-infant transmissions of HIV in two metropolitan areas in the United States. AIDS 11: 325-332.
46. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB 1999. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354: 795-802.
47. Hahn T, Matala E, Chappey C, Ahmad N 1999. Characterization of mother-infant HIV type 1 gag p17 sequences associated with perinatal transmission. AIDS Res Hum Retroviruses 15: 875-888.
48. Halsey NA, Markham R, Wahren B, Boulos R, Rossi P, Wigzell H 1992. Lack of association between maternal antibodies to V3 loop peptides and HIV-1 transmission. AIDS 5: 153-157.
49. Hengel RL, Kennedy MS, Steketee RW, Thea DM, Abrams EJ, Lambert G, McDougal JS 1998. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS Res Hum Retroviruses 14: 475-481.
50. Hershow RC, Riester KA, Lew J, Quinn TC, Mofenson LM, Davenny K, Landesman S, Cotton D, Hanson IC, Hillyer GV, Tang HB, Thomas DL 1997. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission Study. J Infect Dis 176: 414-420.
51. Hildreth JEK, Hampton R, Halsey NA 1999. Antibody dependent cell mediated cytotoxicity can protect PBMC from infection by cell-associated HIV-1. Clin Immunol 90: 203-212.
52. Husson RN, Lan Y, Kojima E, Venzon D, Mitsuya H, McIntosh K 1995. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype. J Pediatr 126: 865-871.
53. Hutto C, Zhou Y, He J, Geffin R, Hill M, Scott W, Wood C 1996. Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses. J Virol 70: 3589-3598.
54. Iversen AK, Fugger L, Eugen-Olsen J, Balslev U, Jensen T, Wahl S, Gerstoft J, Mullins JI, Skinhoj P 1998. Cervical human immunodeficiency virus type I shedding is associated with genital beta-chemokine secretion. J Infect Dis 178: 1334-1342.
55. Janini LM, Tanuri A, Schechter M, Peralta JM, Vicente AC, Dela Torre N, Pieniazek NJ, Luo CC, Ramos A, Soriano V, Schochetman G, Rayfield MA, Pieniazek D 1998. Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C. J Infect Dis 177: 227-231.
56. Jansson M, Orlandi P, Scarlatti G, Moschese V, Romiti ML, Cancrini C, Mancia L, Livadiotti S, Castelli-Gattinara G, Rossi P, Halapi E 1997. Role of immunity in maternal-infant HIV-1 transmission. Acta Paediatr Suppl. 421: 39-45.
57. Jenkins M, Landers D, Williams-Herman D, Wara D, Viscarello RR, Hammill HA, Kline MW, Shearer WT, Charlebois ED, Kohl S 1994. Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1. J Infect Dis 170: 308-312.
58. Jin X, Roberts CG, Nixon DF, Cao Y, Ho DD, Walker BD, Muldoon M, Korber BT, Koup RA 1998. Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project Investigators. J Infect Dis 178: 1317-1326 Published erratum appears in J Infect Dis 179: 1593.
59. Kalish LA, Pitt J, Lew J, Landesman S, Diaz C, Hershow R, Hollinger FB, Pagano M, Smeriglio V, Moye J 1997. Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. Women and Infants Transmission Study (WITS). J Infect Dis 175: 712-715.
60. Kalish M, Brown TM, Schoenbaum E, Abrams EJ, Lambert G, Steketee RW, Robbins KE, Thea DM 1998. Viral and host genetic characterization of possible transient infections in perinatally exposed infants. 12th World AIDS Conf., Geneva, Switzerland, Abstract 23312.
61. Kampinga GA, Simonon A, Van de Perre P, Karita E, Msellati P, Goudsmit J 1997. Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology 227: 63-76.
62. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O'Brien SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, Mann DL 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2: 405-411.
63. Khouri YF, McIntosh K, Cavacini L, Posner M, Pagano M, Tuomala R, Marasco WA 1995. Vertical transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest 95: 732-737.
64. Kline MW, Van Dyke RB, Lindsey JC, Gwynne M, Culnane M, Diaz C, Yogev R, McKinney Jr RE, Abrams EJ, Mofenson LM 1999. Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 Team. Pediatrics 103: c62.
65. Kliks SC, Wara DW, Landers DV, Levy JA 1994. Features of HIV-1 that could influence maternal-child transmission. JAMA 272: 467-474.
66. Kostrikis LG, Neumann AU, Thomson B, Korber BT, McHardy P, Karanicolas R, Deutsch L, Huang Y, Lew JF, McIntosh K, Pollack H, Borkowski W, Spiegel HM, Palumbo P, Oleske J, Bardeguez A, Luzuriaga K, Sullivan J, Wolinsky SM, Koup RA, Ho DD, Moore JP 1999. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of HIV-1 to African-American infants. J Virol 73: 10264-10271.
67. Krogstad P, Uittenbogaart CH, Dickover R, Bryson YJ, Plaeger S, Garfinkel A 1999a. Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics. Clin Immunol 92: 25-33.
68. Krogstad P, Wiznia A, Luzuriaga K, Dankner W, Nielsen K, Gersten M, Kerr B, Hendricks A, Boczany B, Rosenberg M, Jung D, Spector SA, Bryson Y 1999b. Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate. Clin Infect Dis 28: 1109-1118.
69. Lallemant M, Baillon A, Lallemant-Le Coeur S, Nzingoula S, Mampaka M, M'Pele P, Barin F, Essex M 1994. Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women. Lancet 343: 1001-1005.
70. Lambert JS, McNamara J, Katz SL, Fenton T, Kang M, Van Cott TC, Livingston R, Hawkins E, Moye J Jr, Borkowsky W, Johnson D, Yogev R, Duliege AM, Francis D, Gershon A, Wara D, Martin N, Levin M, McSherry G, Smith G 1998. Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trial Group (ATCG-218). J Aids Hum Retrovirol 19: 451-461.
71. Lamers SL, Sleasman JW, She JX, Barrie KA, Pomeroy SM, Barrett DJ, Goodenow MM 1994. Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants infected by vertical transmission. J Clin Invest 93: 380-390.
72. Lathey JL, Tsou J, Brinker K, Hsia K, Meyer WA 3rd, Spector AS 1999. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission. J Infect Dis 180: 344-350.
73. Lecuona JE, Aldamiz-Echevarria Azuara L, Eguiluz G C, Trallero EP 1996. Responses to triple viral and tetanus vaccination in HIV-infected children. An Esp Pediatr 44: 317-320.
74. Leitner T, Albert J 1999. The molecular clock of HIV-1 unveiled through analysis of a known transmission history. Proc Natl Acad Sci USA 96: 10752-10757.
75. Leroy V, Newell ML, Dabis F, Peckham C, Van de Perre P, Bulterys M, Kind C, Simonds RJ, Wiktor S, Msellati P 1998. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV. Lancet 352: 597-600. Published erratum appears in Lancet 352: 1154.
76. Lewis SH, Reynolds-Kohler C, Fox HE, Nelson JA 1990. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in 8-week fetuses. Lancet 335: 565-568.
77. Ljunggren K, Moschese V, Broliden PA, Giaquinto C, Quinli I, Fenyö EM, Wahren B, Rossi P, Jondal M 1990. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to HIV-infected mothers. J Infec Dis 161: 198-202.
78. Lorenzi P, Spicher VM, Laubereau B, Hirschel B, Kind C, Rudin C, Irion O, Kaiser L 1998. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS 12: F241-F247.
79. Louisirirotchanakul S, Beddows S, Cheingsong R, Shaffer N, Mastro TD, Likanonsakul S, Wasi C, Taylor GP, Weber JN 1999. Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand. AIDS 21: 259-265.
80. Lu Y, Brosio P, Lafaile M, Li J, Collman RG, Sodroski J, Miller CJ 1996. Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques. J Virol 70: 3045-3050.
81. Mabondzo A, Narwa R, Roques P, Gras GS, Herve F, Parnet-Mathieu F, Lasfargues G, Courpotin C, Dormont D 1998. Lack of correlation between vertical transmission of HIV-1 and maternal antibody titers against autologous virus in human monocytederived macrophages. J Aids Hum Retrovirol 17: 92-94.
82. Mac Donald KS, J Castillo, Embree J, Njenga S, Nagelkerke Nicolas JD, Ngatia I, Mohammed Z 1998. Class I MHC polymorphism and mother to child HIV-1 transmission in Kenya. 12th World AIDS Conf., Geneva, Switzerland, Abstract 31131.
83. Mandelbrot L, Mayaux MJ, Bongain A, Berrebi A, Moudoub-Jeanpetit Y, Benifla JL, Ciraru-Vigneron N, Le Chenadec J, Blanche S, Delfraissy JF 1996. Obstetric factors and mother-to-child transmission of HIV-1: the french perinatal cohorts.Am J Obstetric Gynecol 175: 661.
84. Markham RB, Coberly J, Ruff AJ, Hoover D, Gomez J, Holt E, Desormeaux J, Boulos R, Quinn TC, Halsey NA 1994. Maternal IgGI and IgA antibody to V3 loop consensus sequence and maternal-infant HIV-1 transmission. Lancet 343: 390-391.
85. Mas A, Espanol T, Heredia A, Pedraza MA, Hernandez M, Caragol I, Fernando M, Bertran JM, Alcami J, Soriano V 1999. CCR5 genotype and HIV-1 infection in perinatally-exposed infants. J Infect Dis 38: 9-11.
86. McSherry GD, Shapiro DE, Coombs RW, McGrath N, Frenkel LM, Britto P, Culnane M, Sperling RS 1999. The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076). J Pediatr 134: 717-724.
87. Menu E, Mbopi-Keou FX, Lagaye S, Pissard S, Mauclere P, Scarlatti G, Martin J, Goossens M, Chaouat G, Barre-Sinoussi F 1999. Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1. J Infect Dis 179: 44-51. Published erratum appears in J Infect Dis 179: 1053.
88. Mikyas Y, Aziz N, Harawa N, Gorre M, Neagos N, Nogueira M, Wafer D, Dillon M, Boyer PJ, Bryson YJ, Plaeger S 1997. Immunologic activation during pregnancy: serial measurements of lymphocytic phenotype and serum activation molecules in HIV-1 infected and uninfected women. J Reprod Immunol 33: 157-170.
89. Misrahi M, Teglas JP, N'Go N, Burgard M, Mayaux MJ, Rouzioux C, Delfraissy JF, Blanche S 1998. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. JAMA 279: 277-280.
90. Mock PA, Shaffer N, Bhadrakom C, Siriwasin W, Chotpitayasunondh T, Chearskul S, Young NL, Roongpisuthipong A, Chinayon P, Kalish ML, Parekh B, Mastro TD 1999. Maternal viral load and timing of mother-to-child HIV transmission. Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. AIDS 13: 407-414.
91. Mognetti B, Moussa M, Croitoru J, Menu E, Dormont D, Roques P, Chaouat G 2000. HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates. Clin Exp Immunol 119: 486-492.
92. Moore JP, Burton DR 1999. HIV-1 neutralizing antibodies: how full is the bottle? Nat Med 5: 142-144.
93. Moussa M, Mognetti B, Dubanchet S, Menu E, Roques P, Gras G, Dormont D, Barre-Sinoussi F, Chaouat G 1999. Vertical transmission of HIV: parameters which might affect infection of placental trophoblasts by HIV-1: a review. Biomed Group on the Study of in Utero Transmission of HIV 1. Am J Reprod Immunol 41: 312-319.
94. Mulder-Kampinga GA, Simonon A, Kuiken CL, Dekker J, Scherpbier HJ, van de Perre P, Boer K, Goudsmit J 1995. Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1 ) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J Virol 69: 2285-2296.
95. Mundy DC, Schinazi RE, Gerber AR, Nahmias AJ, Randall HW 1987. HIV isolated from amniotic fluid. Lancet 2: 459.
96. Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB 1999. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS 13: 479-486.
97. Narwa R, Roques P, Courpotin C, Parnet-Mathicu F, Boussin F, Roane A, Marce D, Lasfargues G, Dormont D 1996. Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission. J Virol 70: 4474-4483.
98. Newell ML 1994. Caesarean delivery cuts HIV infection. Nurs Stand 8: 16.
99. Newell ML 1998. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS 12: 831-837.
100. O'Brien KL, Ruff AJ, Louis MA, Desormeaux J, Joseph DJ, McBrien M, Coberly J, Boulos R, Halsey NA 1995. Bacillus Calmette-Guerin complications in children born to HIV-1-infected women with a review of the literature. Pediatrics 95: 414-418.
101. Okamoto Y, Shiosaki K, Eda Y, Tokiyoshi S, Yamaguchi Y, Gojobori T, Hachimori T, Yamazaki S, Hondo M 1997. Father-to-mother-to-infant transmission of HIV-1: clonally transmitted isolate of infant mutates more rapidly than that of the mother and rapidly loses reactivity with neutralizing antibody. Microbiol Immunol 41: 131-138.
102. Olivero OA, Parikka R, Poirier MC, Vahakangas K 1999a. 3′-azido-3′-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT. Mutat Res 428: 41-47.
103. Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Landay AL, Baker R, Stek AM, Khoury MM, Proia LA, Kessler HA, Sha BE, Tarone RE, Poirier MC 1999b. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS 13: 919-925.
104. Ometto L, Zanotto C, Maccabruni A, Caselli D, Truscia D, Giaquinto C, Ruga E, Chieco-Bianchi L, De Rossi A 1995. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS 9: 427-434.
105. Ortigão MB 1995. AIDS em crianças: considerações sobre a transmissão vertical. Cad Saúde Públ RJ 11: 142-148.
106. O'Shea S, Newell ML, Dunn DT, Garcia-Rodriguez MC, Bates I, Mullen J, Rostron T, Corbett K, Aiyer S, Butler K, Smith R, Banatvala JE 1998. Maternal viral load, CD4 cell count and vertical transmission of HIV-1. J Med Virol 54: 113-117.
107. Papadogiannakis N 1997. Traffic of leukocytes through the maternofetal placental interface and its possible consequences. Curr Top Microbiol Immunol 222: 141-157.
108. Parekh BS, Shaffer N, Pau CP, Abrams E, Thomas P, Pollack H, Bamji M, Kaul A, Schochetman G, Rogers M 1991. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study. AIDS 5: 1179-1184.
109. Peckham C, Gibb D 1995. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 333: 298-302.
110. Phuapradit W, Panburana P, Jaovisidha A, Vichitphun N, Kongsin P, Chantratita W, Bhodhiphala P, Pairoj W 1999. Maternal viral load and vertical transmission of HIV-1 in mid-trimester gestation. AIDS 13: 1927-1931.
111. Pitt J, Brambilla D, Reichelderfer P, Landay A, McIntosh K, Burns D, Hillyer GV, Mendez H, Fowler MG 1997. Maternal immunologic and virologie risk factors for infant human immunodeficiency virus type I infection: findings from the Women and Infants Transmission Study. J Infect Dis 175: 567-575.
112. Plaeger S, Bermudez S, Mikyas Y, Harawa N, Dickover R, Mark D, Dillon M, Bryson YJ, Boyer PJ, Sinsheimer JS 1999. Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants. J Inject Dis 179: 1388-1394.
113. Purswani M, Johann-Liang R, Cervia J, Noel GJ 1999. Effect of changing antiretroviral therapy on human immunodeficiency virus viral load: experience with fifty-four perinatally infected children. Pediatr Infect Dis J 18: 512-516.
114. Rasheed S 1998. Infectivity and dynamics of HIV type 1 replication in the blood and reproductive tract of HIV type 1-infected women. AIDS Res Hum Retroviruses Suppl 1: S105-S118.
115. Robertson CA, Mok JY, Froebel KS, Simmonds P, Burns SM, Marsden HS, Graham S 1992. Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus. J Infect Dis 166: 704-709.
116. Rodriguez EM, Mofenson LM, Chang BH, Rich KC, Fowler MG, Smeriglio V, Landesman S, Fox HE, Diaz C, Green K, Hanson IC 1996. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS 10: 273-282.
117. Rogers MF, Shaffer N 1999. Reducing the risk of maternal-infant transmission of HIV by attacking the virus. N Engl J Med 341: 441-442.
118. Roques PA, Gras G, Parnet-Mathieu F, Mabondzo AM, Dollfus C, Narwa R, Marce D, Tranchot-Diallo J, Herve F, Lasfargues G, Courpotin C, Dormont D 1995. Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS 9: F19-F26.
119. Rousseau CM, Just JJ, Abrams EJ, Casabona J, Stein Z, King MC 1997. CCR5del32 in perinatal HIV-1 infection. J Aids Hum Retrovirol 16: 239-242.
120. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C, Valleron AJ 1995. Estimated timing of mother-to-child HIV-1 transmission by use of a Markov model. Am J Epidemiol 142: 1330-1337.
121. Scarlatti G, Hodara V, Rossi P, Muggiasca L, Bucceri A, Albert J, Fenyö EM 1993a. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. Virology 197: 624-629.
122. Scarlatti G, Leitner T, Hodara V, Halapi E, Rossi P, Albert J, Fenyö EM 1993b. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. AIDS (Suppl.) 2: S45-S48.
123. Scarlatti G, Albert J, Rossi P, Hodara V, Biraghi P, Muggiasca L, Fenyö EM 1993c. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis 168: 207-210.
124. Schwartz DH, Sharma UK, Perlman EJ, Blakemore K 1995. Adherence of human immunodeficiency virus-infected lymphocytes to fetal placental cells: a model of maternal -> fetal transmission. Proc Natl Acad Sci USA 92: 978-982.
125. Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR 1994. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 343: 1593-1597.
126. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, Chotpitayasunondh T, Chcarskul S, Roongpisuthipong A, Chinayon P, Karon J, Mastro TD, Simonds RJ 1999. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 353: 773-880.
127. Shapiro DE, Sperling RS, Mandelbrot L, Britto P, Cunningham BE 1999. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group. Obstet Gynecol 94: 897-908.
128. Shearer WT, Langston C, Lewis DE, Pham EL, Hammill HH, Kozinetz CA, Kline MW, Hanson IC, Popek EJ 1997a. Early spontaneous abortions and fetal thymic abnormalities in maternal-to-fetal HIV infection. Acta Paediatr (Suppl.) 421: 60-64.
129. Shearer WT, Reuben J, Lee BM, Popek EJ, Lewis DE, Hammil HH, Hanson IC, Kline MW, Langston C 1997b. Role of placental cytokines and inflammation in vertical transmission of HIV infection. Acta Paediatr (Suppl.) 421: 33-38.
130. Shearer WT, Kalish LA, Zimmerman PA 1998. CCR5 HIV-1 vertical transmission. Women and Infants Transmission Study Group. J Aids Hum Retrovirol 17: 180-181.
131. Sheppard HW, Lang W, Ascher MS, Vittinghoff E, Winkelstein W 1993. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS 7: 1159-1166.
132. Sienna Workshop: report of a consensus workshop, Siena, Italy, Jan 17-18, 1992. Maternal factors involved in mother-to-child transmission of HIV-1. AIDS 5: 1019-1025.
133. Simpson RM, Hubbard BS, Zhao TM, Kindt TJ 1997. Experimental perinatal transmission of human immunodeficiency virus type 1 by passage of infected T cells. J Infect Dis 175: 1337-1343.
134. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL 1996. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 335: 1621-1629.
135. Stiehm ER, Lambert JS, Mofenson LM, Bethel J, Whitehouse J, Nugent R, Moye Jr J, Glenn Fowler M, Mathieson BJ, Reichelderfer P, Nemo GJ, Korelitz J, Meyer WA 3rd, Sapan CV, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H 1999. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group Protocol 185. J Infect Dis 179: 567-575.
136. St. Louis E, Kamenga M, Brown C 1993. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic and placental factors. JAMA 269: 2853.
137. Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TD 1998. Infant feeding and risk of mother-to-child transmission of HIV-1 in São Paulo State, Brazil. São Paulo Collaborative Study for Vertical Transmission of HIV-1. J Aids Hum Retrovirol 19: 189-194. Published erratum appears in J Aids Hum Retrovirol 19: 550.
138. Thaineua V, Sirinirund P, Tanbanjong A, Lallemant M, Soucat A, Lamboray JL 1998. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand. Southeast Asian J Trop Med Public Health 29: 429-442.
139. Thea DM, Steketee RW, Pliner V, Bornschlegel K, Brown T, Orloff S, Matheson PB, Abrams EJ, Bamji M, Lambert G, Schoenbaum EA, Thomas PA, Heagarty M, Kalish ML and the New York City Perinatal HIV Transmission Collaborative Study Group 1997. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. AIDS 11: 437-444.
140. Tscherning-Casper C, Papadogiannakis N, Anvret M, Stolpe L, Liridgren S, Bohlin AB, Albert J, Fenyö EM 1999. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol 73: 9673-9678.
141. Ugen KE, Srikantan V, Goedert JJ, Nelson Jr RP, Williams WV, Weiner DB 1997. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotcin. J Infect Dis 175: 63-69.
142. Van de Perre P 1999a. Mother-to-child transmission of HIV-1: the 'all mucosal' hypothesis as a predominant mechanism of transmission. AIDS 13: 1133-1138.
143. Van de Perre P 1999b. Transmission of human immunodeficiency virus type 1 through breast-feeding, how can it be prevented? J Infect Dis 179 (Suppl. 3): S405-S407.
144. Wabwire-Mangen F, Gray RH, Miro FA, Ndugwa C, Abramowsky C, Wabinga H, Whalen C, Li C, Saah AJ 1999. Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda. AIDS 22: 379-385.
145. Wade CM, Lobdiel D, Brown AJ 1998. Analysis of HIV-1 env and gag sequence variants derived from a mother and two vertically infected children provides evidence for the transmission of multiple sequence variants. J Gen Virol 79: 1055-1068.
146. Wasik TJ, Bratosiewicz J, Wierzbicki A, Whiteman VE, Rutstein RR, Starr SK, Douglas SD, Kaufman D, Sison AV, Polansky M, Lischner HW, Kozbor D 1999. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol 162: 4355-4364.
147. Weiser B, Nachman S, Tropper P 1994. Quantitation of HIV-1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 91: 8037.
148. Wike CM, Korber BT, Daniels MR, Hutto C, Munoz J, Furtado M, Parks W, Saah A, Bulterys M, Kurawige JB, Wolinsky SM 1992. HIV-1 sequence variation between isolates from mother-infant transmission pairs. Aids Res Hum Retroviruses 8: 1297-1300.
149. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, Roels TH, Kouassi MK, Lackritz EM, Coulibaly IM, Greenberg AE 1999. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan. Cote d'Ivoire: a randomised trial. Lancet 353: 781-785.
150. Wilson CC, Brown RC, Korber BT, Wilkes BM, Ruhl DJ, Sakamoto D, Kunstman K, Luzuriaga K, Hanson IC, Widmayer SM, Wiznia A, Clapp S, Ammann AJ, Koup RA, Wolinsky SM, Walker BD 1999. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission, the ariel project for the prevention of transmission of HR from mother to infant. J Virol 73: 3975-3985.
151. Wolinsky SM, Wike CM, Korber BT, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, Munoz JL 1992. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255: 1134-1137.
152. Workshop Report from the European Commission (DG XII, INCO-DC) and Joint United Nations Programme on HIV/AIDS 1997: HIV-1 subtypes: implications for epidemiology, pathogenicity, vaccines and diagnostics. AIDS 11: UNAIDS17-UNAIDS36.
153. Wright PF, Lambert JS, Gorse GJ, Hsich RH, McElrath MJ, Weinhold C, Wara DW, Anderson EL, Keefer MC, Jackson S, Wagner LJ, Francis DP, Fast PE, McNamara J 1999. Immunization with envelope MN gp120 vaccine in human immunodeficiency virus-infected pregnant women. J Infect Dis 180: 1080-1088.
154. Zeichner SL, Palumbo P, Feng Y, Xiao X, Gee D, Sleasman J, Goodenow M, Biggar R, Dimitrov D 1999. Rapid telomere shortening in children. Blood 93: 2824-2830.
155. Zöllner B, Feucht HH, Mattner UM, Helling-Giese G, Baumgartner EM, Laufs R 1996. Better prediction of vertical HIV-1 transmission from maternal blood at delivery compared with cord blood samples. AIDS 10: 1600-1601.
156. Zöllner B, Feucht HH, Hielling-Giese G, Mattner UM, Schartl W, Polywka S, Laufs R 1997. Threshold of HIV-1 copy numbers for vertical transmission. AIDS 11: 542-543.
157. Zöllner B, Feucht HH, Mattner UM, Helling-Giese G, Baumgartner EM, Laufs R 1996. Better prediction of vertical HIV-1 transmission from maternal blood at delivery compared with cord blood samples . AIDS 10: 1600-1601.
158. Zorilla CD 2000. Mother-to-child HIV-1 transmission: state of art and implications for public policy. PR Health Sci J 19: 29-34.